Elena Lum, Ph.D. - Publications

Affiliations: 
2013 Molecular and Cellular Biology Stony Brook University, Stony Brook, NY, United States 
Area:
Molecular Biology, Oncology

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Lum E, Vigliotti M, Banerjee N, Cutter N, Wrzeszczynski KO, Khan S, Kamalakaran S, Levine DA, Dimitrova N, Lucito R. Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis. Gynecologic Oncology. 130: 369-76. PMID 23684582 DOI: 10.1016/J.Ygyno.2013.05.002  0.698
2013 Lum E, Vigliotti M, Banerjee N, Cutter N, Kamalakaran S, Wrzeszczynski K, Khan S, Dimitrova N, Levine D, Lucito R. Abstract 2988: DOK2 suppression by methylation induces platinum resistance via suppression of apoptosis in ovarian cancer cells. Cancer Research. 73: 2988-2988. DOI: 10.1158/1538-7445.Am2013-2988  0.707
2013 Vigliotti M, Lum E, Banerjee n, Cutter N, Wrzeszczynski KO, Khan S, Kamalakaran S, Levine DA, Dimitrova N, Lucito R. Abstract A46: Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A46  0.869
2013 Cutter NL, Yacoub M, Lucito RD, Dimitrova N, Lum E, Vigliotti M, Wrzeszczynski K, Levine DA. Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A24  0.872
2012 NLCPD, Lum E, Vigliotti M, Khan S, Levine D, Dimitrova N, Lucito R. Abstract 3144: A role for DOK2 methylation in platinum resistance and tumor suppression in ovarian cancer Cancer Research. 72: 3144-3144. DOI: 10.1158/1538-7445.Am2012-3144  0.834
2012 Cutter N, Vigliotti M, Lum E, Wrzeszczynski KO, Varadan V, Dimitrova N, Levine DA, Lucito R. Abstract 1047: Suppression of the chromatin remodeling protein CHD3 and platinum resistance in ovarian cancer Cancer Research. 72: 1047-1047. DOI: 10.1158/1538-7445.Am2012-1047  0.698
2011 Wrzeszczynski KO, Varadan V, Byrnes J, Lum E, Kamalakaran S, Levine DA, Dimitrova N, Zhang MQ, Lucito R. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. Plos One. 6: e28503. PMID 22174824 DOI: 10.1371/Journal.Pone.0028503  0.761
Show low-probability matches.